|
1
|
Wasserman M, Baxter NN, Rosen B, Burnstein
M and Halverson AL: Systematic review of internet patient
information on colorectal cancer surgery. Dis Colon Rectum.
57:64–69. 2014. View Article : Google Scholar
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
George S, Wang Q, Heinrich MC, Corless CL,
Zhu M, Butrynski JE, Morgan JA, Wagner AJ, Choy E, Tap WD, et al:
Efficacy and safety of regorafenib in patients with metastatic
and/or unresectable GI stromal tumor after failure of imatinib and
sunitinib: A multicenter phase II trial. J Clin Oncol.
30:2401–2407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vacchelli E, Eggermont A, Galon J,
Sautès-Fridman C, Zitvogel L, Kroemer G and Galluzzi L: Trial
watch: Monoclonal antibodies in cancer therapy. OncoImmunology.
2:e227892013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Challen GA and Little MH: A side order of
stem cells: The SP phenotype. Stem Cells. 24:3–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang W, Peng J, Zhang Y, Cho WC and Jin
K: The implications of cancer stem cells for cancer therapy. Int J
Mol Sci. 13:16636–16657. 2012. View Article : Google Scholar
|
|
7
|
Clevers H: The cancer stem cell: Premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dick JE: Stem cell concepts renew cancer
research. Blood. 112:4793–4807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
10
|
Maugeri-Sacca M, Vigneri P and De Maria R:
Cancer stem cells and chemosensitivity. Clin Cancer Res.
17:4942–4947. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Irvin DK, Jouanneau E, Duvall G, Zhang XX,
Zhai Y, Sarayba D, Seksenyan A, Panwar A, Black KL and Wheeler CJ:
T cells enhance stem-like properties and conditional malignancy in
gliomas. PLoS One. 5:e109742010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Awad O, Yustein JT, Shah P, Gul N, Katuri
V, O'Neill A, Kong Y, Brown ML, Toretsky JA and Loeb DM: High ALDH
activity identifies chemotherapy-resistant Ewing's sarcoma stem
cells that retain sensitivity to EWS-FLI1 inhibition. PLoS One.
5:e139432010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cameron SR, Dahler AL, Endo-Munoz LB,
Jabbar I, Thomas GP, Leo PJ, Poth K, Rickwood D, Guminski A and
Saunders NA: Tumor-initiating activity and tumor morphology of
HNSCC is modulated by interactions between clonal variants within
the tumor. Lab Invest. 90:1594–1603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Michishita M, Akiyoshi R, Yoshimura H,
Katsumoto T, Ichikawa H, Ohkusu-Tsukada K, Nakagawa T, Sasaki N and
Takahashi K: Characterization of spheres derived from canine
mammary gland adenocarcinoma cell lines. Res Vet Sci. 91:254–260.
2011. View Article : Google Scholar
|
|
16
|
Smith BH, Gazda LS, Conn BL, Jain K, Asina
S, Levine DM, Parker TS, Laramore MA, Martis PC, Vinerean HV, et
al: Three-dimensional culture of mouse renal carcinoma cells in
agarose macrobeads selects for a subpopulation of cells with cancer
stem cell or cancer progenitor properties. Cancer Res. 71:716–724.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Overdevest JB, Thomas S, Kristiansen G,
Hansel DE, Smith SC and Theodorescu D: CD24 offers a therapeutic
target for control of bladder cancer metastasis based on a
requirement for lung colonization. Cancer Res. 71:3802–3811. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang KH, Dai YD, Tong M, Chan YP, Kwan PS,
Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, et al: A CD90(+)
tumor-initiating cell population with an aggressive signature and
metastatic capacity in esophageal cancer. Cancer Res. 73:2322–2332.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blacking TM, Waterfall M and Argyle DJ:
CD44 is associated with proliferation, rather than a specific
cancer stem cell population, in cultured canine cancer cells. Vet
Immunol Immunopathol. 141:46–57. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schöler HR, Ruppert S, Suzuki N, Chowdhury
K and Gruss P: New type of POU domain in germ line-specific protein
Oct-4. Nature. 344:435–439. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okumura-Nakanishi S, Saito M, Niwa H and
Ishikawa F: Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic
stem cells. J Biol Chem. 280:5307–5317. 2005. View Article : Google Scholar
|
|
22
|
Biswas C: Tumor cell stimulation of
collagenase production by fibroblasts. Biochem Biophys Res Commun.
109:1026–1034. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hao JL, Cozzi PJ, Khatri A, Power CA and
Li Y: CD147/EMMPRIN and CD44 are potential therapeutic targets for
metastatic prostate cancer. Curr Cancer Drug Targets. 10:287–306.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zou W, Yang H, Hou X, Zhang W, Chen B and
Xin X: Inhibition of CD147 gene expression via RNA interference
reduces tumor cell invasion, tumorigenicity and increases
chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett.
248:211–218. 2007. View Article : Google Scholar
|
|
25
|
Sidhu SS, Nawroth R, Retz M,
Lemjabbar-Alaoui H, Dasari V and Basbaum C: EMMPRIN regulates the
canonical Wnt/beta-catenin signaling pathway, a potential role in
accelerating lung tumorigenesis. Oncogene. 29:4145–4156. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gerrard L, Zhao D, Clark AJ and Cui W:
Stably transfected human embryonic stem cell clones express
OCT4-specific green fluorescent protein and maintain self-renewal
and pluripotency. Stem Cells. 23:124–133. 2005. View Article : Google Scholar
|
|
27
|
Rothermund K, Rogulski K, Fernandes E,
Whiting A, Sedivy J, Pu L and Prochownik EV: C-Myc-independent
restoration of multiple phenotypes by two C-Myc target genes with
overlapping functions. Cancer Res. 65:2097–2107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsai KS, Yang SH, Lei YP, Tsai CC, Chen
HW, Hsu CY, Chen LL, Wang HW, Miller SA, Chiou SH, et al:
Mesenchymal stem cells promote formation of colorectal tumors in
mice. Gastroenterology. 141:1046–1056. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Higashi K, Yagi M, Arakawa T, et al: A
novel marker for undifferentiated human embryonic stem cells.
Monoclon Antib Immunodiagn Immunother. 34:7–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
31
|
Diehn M, Cho RW and Clarke MF: Therapeutic
implications of the cancer stem cell hypothesis. Semin Radiat
Oncol. 19:78–86. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leal JA and Lleonart ME: MicroRNAs and
cancer stem cells: Therapeutic approaches and future perspectives.
Cancer Lett. 338:174–183. 2013. View Article : Google Scholar
|
|
33
|
Medema JP: Cancer stem cells: The
challenges ahead. Nat Cell Biol. 15:338–344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zöller M: CD44: Can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su YJ, Lai HM, Chang YW, Chen GY and Lee
JL: Direct reprogramming of stem cell properties in colon cancer
cells by CD44. EMBO J. 30:3186–3199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sajithlal GB, Rothermund K, Zhang F, Dabbs
DJ, Latimer JJ, Grant SG and Prochownik EV: Permanently blocked
stem cells derived from breast cancer cell lines. Stem Cells.
28:1008–1018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kang MJ, Kim HP, Lee KS, Yoo YD, Kwon YT,
Kim KM, Kim TY and Yi EC: Proteomic analysis reveals that
CD147/EMMPRIN confers chemoresistance in cancer stem cell-like
cells. Proteomics. 13:1714–1725. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hao J, Chen H, Madigan MC, Cozzi PJ,
Beretov J, Xiao W, Delprado WJ, Russell PJ and Li Y: Co-expression
of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate
transporters is associated with prostate cancer drug resistance and
progression. Br J Cancer. 103:1008–1018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Slomiany MG, Grass GD, Robertson AD, Yang
XY, Maria BL, Beeson C and Toole BP: Hyaluronan, CD44, and emmprin
regulate lactate efflux and membrane localization of
monocarboxylate transporters in human breast carcinoma cells.
Cancer Res. 69:1293–1301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim KM and Yi EC: CD147 is critical for
cancer stem cell chemoresistance: what does this mean for the
clinic? Expert Rev Proteomics. 10:313–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bartucci M, Svensson S, Romania P, Dattilo
R, Patrizii M, Signore M, Navarra S, Lotti F, Biffoni M, Pilozzi E,
et al: Therapeutic targeting of Chk1 in NSCLC stem cells during
chemotherapy. Cell Death Differ. 19:768–778. 2012. View Article : Google Scholar :
|
|
42
|
Yang X, Zhang P, Ma Q, Kong L, Li Y, Liu B
and Lei D: EMMPRIN contributes to the in vitro invasion of human
salivary adenoid cystic carcinoma cells. Oncol Rep. 27:1123–1127.
2012.
|
|
43
|
Li M, Zhai Q, Bharadwaj U, Wang H, Li F,
Fisher WE, Chen C and Yao Q: Cyclophilin A is overexpressed in
human pancreatic cancer cells and stimulates cell proliferation
through CD147. Cancer. 106:2284–2294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xu T, Zhou M, Peng L, Kong S, Miao R, Shi
Y, Sheng H and Li L: Upregulation of CD147 promotes cell invasion,
epithelial-to-mesenchymal transition and activates MAPK/ERK
signaling pathway in colorectal cancer. Int J Clin Exp Pathol.
7:7432–7441. 2014.
|
|
45
|
Rau KM, Kang HY, Cha TL, Miller SA and
Hung MC: The mechanisms and managements of hormone-therapy
resistance in breast and prostate cancers. Endocr Relat Cancer.
12:511–532. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Misra S, Ghatak S, Zoltan-Jones A and
Toole BP: Regulation of multidrug resistance in cancer cells by
hyaluronan. J Biol Chem. 278:25285–25288. 2003. View Article : Google Scholar : PubMed/NCBI
|
